Pharmaceutical Stocks Get Boost from Swine Flu?
Filed under: Wealth
Pandemic spells profit for pharmaceutical giants like Sanofi-Aventis (SNY), GlaxoSmithKline (GSK) and Merck who represent the top three producers of vaccines to treat H1N1 or swine flu. A couple weeks ago the World Health Organization prepared to declare the first worldwide pandemic in four decades and with that news the aforementioned pharmaceutical stocks began to rise 1%-2.2% on the board. At that time 27,737 H1N1 infections had been reported across seventy-four countries including 141 deaths. Countries across the globe will be inclined to increase flu-vaccine stockpiles in the hopes of controlling the potential pandemic within their borders.When the bird flu, H5N1, was a pandemic threat a few years ago the mere production of an effective bird-flu vaccine paired with a successful clinical trial by GlaxoSmithKline impacted their second quarter positively with a 14% rise in net profits and an 11% rise in sales. At the time it was estimated that the H5N1 vaccine could potentially garner $2 million in annual sales for Glaxo. Impressive!
This just goes to show that not all stocks are in peril -- the human population may be, but that's another story.

Live from Microsoft's New Generation Xbox event!
Xbox Reveal liveblog on Joystiq
The List #0147: Escape a Car Underwater
Xbox One architecture panel liveblog!
H&M's Plus-Size Model Jennie Runk Says She Chose To Gain Weight
Okla. Sheriff's Deputy Finds Dog Guarding Body Buried Under Destroyed Home
Reptiles Make Home in UK Man's Cable Box
Okla. School Survivor: Teacher 'Saved Our Lives'
Xbox One event roundup: Microsoft reveals its next-gen gaming console